article Drug Discovery Generative AI Quantum Chemistry

Integrating QSAR modelling and deep learning in drug discovery: the emergence of deep QSAR

Alexander Tropsha, Olexandr Isayev, Alexandre Varnek, Gisbert Schneider, Artem Cherkasov

Nat. Rev. Drug Discov. 2024

Abstract

Quantitative structure-activity relationship (QSAR) modelling, an approach that was introduced 60 years ago, is widely used in computer-aided drug design. In recent years, progress in artificial intelligence techniques, such as deep learning, the rapid growth of databases of molecules for virtual screening and dramatic improvements in computational power have supported the emergence of a new field of QSAR applications that we term 'deep QSAR'. Marking a decade from the pioneering applications of deep QSAR to tasks involved in small-molecule drug discovery, we herein describe key advances in the field, including deep generative and reinforcement learning approaches in molecular design, deep learning models for synthetic planning and the application of deep QSAR models in structure-based virtual screening. We also reflect on the emergence of quantum computing, which promises to further accelerate deep QSAR applications and the need for open-source and democratized resources to support computer-aided drug design.

Keywords

Cite This Paper

@article{Tropsha2024,
  author = {Tropsha, Alexander and Isayev, Olexandr and Varnek, Alexandre and Schneider, Gisbert and Cherkasov, Artem},
  title = {Integrating QSAR modelling and deep learning in drug discovery: the emergence of deep QSAR},
  year = {2024},
  journal = {Nat. Rev. Drug Discov.},
  doi = {10.1038/s41573-023-00832-0},
  keywords = {neural networks, molecular design, deep reinforcement learning, qsar applications, computational power},
  researchAreas = {drug-discovery, generative-ai, quantum-chemistry}
}

Related Research Areas

Related Publications

2018
cited 1196

Deep reinforcement learning for de novo drug design

Popova M. , Isayev O. , Tropsha A.

Science Advances , 4 (2018)

Generative Ai
Drug Discovery
DOI
2023
cited 231

Generative Models as an Emerging Paradigm in the Chemical Sciences

Anstine D. M. , Isayev O.

Journal of the American Chemical Society , 145 , 8736–8750 (2023)

Generative Ai
Drug Discovery
DOI
2022
cited 84

Generative and reinforcement learning approaches for the automated de novo design of bioactive compounds

Korshunova M. , Huang N. , Capuzzi S. , Radchenko D. S. , Savych O. , Moroz Y. S. , Wells C. I. , Willson T. M. , Tropsha A. , Isayev O.

Communications Chemistry , 5 (2022)

Generative Ai
Drug Discovery
DOI
2022
cited 225

The transformational role of GPU computing and deep learning in drug discovery

Pandey M. , Fernandez M. , Gentile F. , Isayev O. , Tropsha A. , Stern A. C. , Cherkasov A.

Nature Machine Intelligence , 4 , 211–221 (2022)

Drug Discovery
Generative Ai
DOI
2025
cited 8

Machine learning interatomic potentials at the centennial crossroads of quantum mechanics

Kalita B. , Gokcan H. , Isayev O.

Nature Computational Science , 5 , 1120–1132 (2025)

Ml Potentials
Quantum Chemistry
Generative Ai
DOI